Sotera Health Co
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
SHC$16.27-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)Documents Filed with Report
(1)Consolidated Financial Statements
The consolidated financial statements are filed as part of this Annual Report on Form 10-K under Item 8, “Financial Statements and Supplementary Data”
(2)Financial Statement Schedules
Schedule II - Valuation and Qualifying Accounts for the years ended December 31, 2023, 2022 and 2021
All other schedules for which provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable, and therefore, have been omitted.
(3)Exhibits
The exhibits listed in the following Exhibit Index are filed, furnished, or incorporated by reference as part of this Annual Report on Form 10-K.
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit No | Description of Exhibits | Filed/Furnished Herewith | Form | File No. | Exhibit | Filing Date |
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant | 10-K | 001-39729 | 3.1 | 2021-03-09 | |
| 3.2 | Amended and Restated Bylaws of the Registrant | 10-K | 001-39729 | 3.2 | 2021-03-09 | |
| 4.1 | Description of our Common Stock | 10-K | 001-39729 | 4.1 | 2021-03-09 | |
| 4.2 | Amended and Restated Registration Rights Agreement | 10-K | 001-39729 | 4.2 | 2021-03-09 | |
| 10.1+ | Employment Agreement by and between Sotera Health Company and Michael B. Petras, Jr., dated as of November 10, 2020 | S-1/A | 333-249648 | 10.1 | 2020-11-12 | |
| 10.2+ | Executed Employment Offer by Sotera Health Company and Michael F. Biehl dated as of July 18, 2022 | 10-K | 001-39729 | 10.5 | 2023-02-28 | |
| 10.3+ | Executed Restrictive Covenants Agreement by and between Sotera Health Company and Michael F. Biehl dated as of July 20, 2022 | 10-K | 001-39729 | 10.6 | 2023-02-28 | |
| 10.4+ | Executed Employment Offer by Sotera Health Company and Alex Dimitrief dated as of October 28, 2022 | 10-K | 001-39729 | 10.7 | 2023-02-28 | |
| 10.5+ | Executed Restrictive Covenants Agreement by and between Sotera Health Company and Alex Dimitrief, dated as of November 1, 2022 | 10-K | 001-39729 | 10.8 | 2023-02-28 | |
| 10.6+ | Cash Retention Bonus Agreement by and between Michael Rutz and Sotera Health Company dated as of November 7, 2022 | 10-K | 001-39729 | 10.9 | 2023-02-28 | |
| 10.7+ | Executed Amended and Restated Employment Offer by Sotera Health Company and Jonathan M. Lyons dated as of February 26, 2024 | * | ||||
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit No · Description of Exhibits · Filed/Furnished Herewith · Form · File No. · Exhibit · Filing Date | |||||
| 10.8+ | Executed Restrictive Covenants Agreement by and between Sotera Health Company and Jonathan M. Lyons dated as of June 26, 2023 | 10-Q | 001-39729 | 10.3 | 2023-08-03 |
| 10.9+ | Sotera Health Company Supplemental Retirement Benefit Plan, effective as of January 1, 2018 | S-1/A | 333-249648 | 10.4 | 2020-11-12 |
| 10.10+ | Sotera Health Company 2020 Omnibus Incentive Plan | S-1/A | 333-249648 | 10.5 | 2020-11-12 |
| 10.11+ | Form of Sotera Health Company 2020 Omnibus Incentive Plan Restricted Stock Unit Grant Notice and Agreement | S-1/A | 333-249648 | 10.6 | 2020-11-12 |
| 10.12+ | Form of Sotera Health Company 2020 Omnibus Incentive Plan Stock Option Grant Notice and Agreement | S-1/A | 333-249648 | 10.7 | 2020-11-12 |
| 10.13 | Form of Indemnification Agreement entered into between the Registrant and each director and executive officer | S-1/A | 333-249648 | 10.8 | 2020-11-02 |
| 10.14 | Stockholders’ Agreement | 10-K | 001-39729 | 10.9 | 2021-03-09 |
| 10.15 | 2019 Credit Agreement, dated as of December 13, 2019, among the Registrant, Sotera Health Holdings, LLC, the lenders and issuing banks party thereto and Jefferies Finance LLC, as first lien administrative agent and first lien collateral agent | S-1 | 333-249648 | 10.10 | 2020-10-23 |
| 10.16 | Guarantee Agreement, dated as of December 13, 2019, among the Registrant, Sotera Health Holdings, LLC, the other guarantors party thereto and Jefferies Finance LLC, as first lien collateral agent | S-1 | 333-249648 | 10.11 | 2020-10-23 |
| 10.17 | Collateral Agreement, dated as of December 13, 2019, among the Registrant, Sotera Health Holdings, LLC, the other guarantors party thereto and Jefferies Finance LLC, as first lien collateral agent | S-1 | 333-249648 | 10.12 | 2020-10-23 |
| 10.18 | Patent Security Agreement, dated as of December 13, 2019, between Sterigenics U.S., LLC and Jefferies Finance LLC, as collateral agent | S-1 | 333-249648 | 10.13 | 2020-10-23 |
| 10.19 | Trademark Security Agreement, dated as of December 13, 2019, between Sterigenics U.S., LLC and Jefferies Finance LLC, as collateral agent | S-1 | 333-249648 | 10.14 | 2020-10-23 |
| 10.20 | Trademark Security Agreement, dated as of December 13, 2019, between Nelson Laboratories, LLC and Jefferies Finance LLC, as collateral agent | S-1 | 333-249648 | 10.15 | 2020-10-23 |
| 10.21 | Trademark Security Agreement, dated as of December 13, 2019, between Sotera Health LLC and Jefferies Finance LLC, as collateral agent | S-1 | 333-249648 | 10.16 | 2020-10-23 |
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit No · Description of Exhibits · Filed/Furnished Herewith · Form · File No. · Exhibit · Filing Date | |||||
| 10.22 | Copyright Security Agreement, dated as of December 13, 2019, among Jefferies Finance LLC and Nelson Laboratories, LLC, as collateral agent | S-1 | 333-249648 | 10.17 | 2020-10-23 |
| 10.23 | First Lien Pari Passu Intercreditor Agreement, dated as of July 31, 2020, among Sotera Health Holdings, LLC, the Registrant, Jefferies Finance LLC as Collateral Agent and Authorized Representative, and Wilmington Trust, National Association as Additional First Lien Collateral Agent and Initial Authorized Representative | S-1 | 333-249648 | 10.25 | 2020-10-23 |
| 10.24 | First Lien Collateral Agreement, dated as of July 31, 2020, among the Registrant, Sotera Health Holdings, LLC, the other grantors party thereto and Wilmington Trust, National Association, as first lien notes collateral agent | S-1 | 333-249648 | 10.26 | 2020-10-23 |
| 10.25 | Patent Security Agreement, dated as of July 31, 2020, between Sterigenics U.S., LLC and Wilmington Trust, National Association, as first lien notes collateral agent | S-1 | 333-249648 | 10.27 | 2020-10-23 |
| 10.26 | Trademark Security Agreement, dated as of July 31, 2020, between Sotera Health Holdings LLC and Wilmington Trust, National Association, as first lien notes collateral agent | S-1 | 333-249648 | 10.28 | 2020-10-23 |
| 10.27 | Copyright Security Agreement, dated as of July 31, 2020, between Nelson Laboratories, LLC and Wilmington Trust, National Association, as first lien notes collateral agent | S-1 | 333-249648 | 10.29 | 2020-10-23 |
| 10.28† | Restated Supply Agreement, dated as of October 6, 2020, between Balchem Corporation and Sterigenics U.S., LLC, Sterigenics S. De R.L. De C.V., Sterigenics Costa Rica S.R.L. and Sterigenics EO Canada, Inc. | S-1/A | 333-249648 | 10.30 | 2020-11-18 |
| 10.29+ | Form of Restricted Stock Agreement and Acknowledgement | S-1/A | 333-249648 | 10.31 | 2020-11-12 |
| 10.30+ | Non-Employee Director Compensation Policy | S-1/A | 333-249648 | 10.32 | 2020-11-12 |
| 10.31+ | Employment Agreement by and between Sotera Health LLC and Michael P. Rutz, dated as of May 21, 2020 | 10-K | 001-39729 | 10.26 | 2021-03-09 |
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit No · Description of Exhibits · Filed/Furnished Herewith · Form · File No. · Exhibit · Filing Date | |||||
| 10.32 | Incremental Facility Amendment to the 2019 Credit Agreement, dated as of December 17, 2020, among Sotera Health Company, Sotera Health Holdings, LLC, the Incremental Amendment Revolving Lends party thereto, Jefferies Finance LLC, as First Lien Administrative Agent, each Issuing Bank and the Other Loan Parties | 10-K | 001-39729 | 10.27 | 2021-03-09 |
| 10.33 | Refinancing Amendment to the First Lien 2019 Credit Agreement, dated as of January 20, 2021, among Sotera Health Company, Sotera Health Holdings, LLC, the Refinancing Lenders Party thereto, the Revolving Lenders party to the First Lien Credit Agreement and Jefferies Finance LLC, as First Lien Administrative Agent and First Lien Collateral Agent | 10-K | 001-39729 | 10.28 | 2021-03-09 |
| 10.34 | Revolving Facilities Amendment to the 2019 Credit Agreement, dated as of March 26, 2021, among Sotera Health Company, Sotera Health Holdings, LLC, the Refinancing Lenders Party thereto, the Revolving Lenders party to the First Lien Credit Agreement and Jefferies Finance LLC, as First Lien Administrative Agent and First Lien Collateral Agent | 10-Q | 001-39729 | 10.2 | 2021-05-13 |
| 10.35 | Amendment to First Lien 2019 Credit Agreement, dated as of December 23, 2021 by and among Sotera Health Company, Sotera Health Holdings, LLC, and JPMorgan Chase Bank, N.A. as First Lien Administrative Agent and First Lien Collateral Agent | 10-K | 001-39729 | 10.31 | 2022-03-01 |
| 10.36 | Amendment to First Lien 2019 Credit Agreement, dated as of March 24, 2022, by and among Sotera Health Company, Sotera Health Holdings, LLC, and JPMorgan Chase Bank, N.A. as First Lien Administrative Agent | 10-K | 001-39729 | 10.37 | 2023-02-28 |
| 10.37 | 2023 Credit Agreement dated as of February 23, 2023 among the Registrant, Sotera Health Holdings, LLC, the Lenders party thereto and JPMorgan Chase Bank, N.A., as First Lien Administrative Agent and First Lien Collateral Agent | 10-K | 001-39729 | 10.38 | 2023-02-28 |
| 10.38 | First Lien Guarantee Agreement dated as of February 23, 2023, among the Registrant, Sotera Health Holdings, LLC, the other guarantors party thereto and JPMorgan Chase Bank, N.A., as First Lien Collateral Agent | 10-K | 001-39729 | 10.39 | 2023-02-28 |
| 10.39 | First Lien Collateral Agreement dated as of February 23, 2023, among the Registrant, Sotera Health Holdings, LLC, the other grantors party thereto and JPMorgan Chase Bank, N.A., as First Lien Collateral Agent | 10-K | 001-39729 | 10.40 | 2023-02-28 |
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit No · Description of Exhibits · Filed/Furnished Herewith · Form · File No. · Exhibit · Filing Date | |||||
| 10.40 | First Lien Pari Passu Intercreditor Agreement dated as of February 23, 2023, among Sotera Health Holdings, LLC, the Registrant, the other grantors party thereto and JPMorgan Chase Bank, N.A. | 10-K | 001-39729 | 10.41 | 2023-02-28 |
| 10.41 | Copyright Security Agreement, dated as of February 23, 2023, among Nelson Laboratories, LLC and JPMorgan Chase Bank, N.A., as collateral agent | 10-K | 001-39729 | 10.42 | 2023-02-28 |
| 10.42 | Trademark Security Agreement, dated as of February 23, 2023, among Nelson Laboratories Bozeman, LLC and JPMorgan Chase Bank, N.A., as collateral agent | 10-K | 001-39729 | 10.43 | 2023-02-28 |
| 10.43 | Trademark Security Agreement, dated as of February 23, 2023, among Regulatory Compliance Associates Inc. and JPMorgan Chase Bank, N.A., as collateral agent | 10-K | 001-39729 | 10.44 | 2023-02-28 |
| 10.44 | Trademark Security Agreement, dated as of February 23, 2023, among Sotera Health Holdings, LLC and JPMorgan Chase Bank, N.A., as collateral agent | 10-K | 001-39729 | 10.45 | 2023-02-28 |
| 10.45 | Incremental Facility Amendment No. 2, dated as of March 21, 2023, to the First Lien Credit Agreement dated as of December 13, 2019 by and among Sotera Health Company, Sotera Health Holdings, LLC, certain subsidiaries of Sotera Health Company, JPMorgan Chase Bank, N.A., as First Lien Administrative Agent and the lenders and issuing banks party thereto | 8-K | 001-39729 | 10.1 | 2023-03-22 |
| 10.46 | Amendment, dated as of June 22, 2023, to the First Lien Credit Agreement dated as of December 13, 2019 by and among Sotera Health Company, Sotera Health Holdings, LLC, certain subsidiaries of Sotera Health Company, JPMorgan Chase Bank, N.A., as First Lien Administrative Agent and the lenders and issuing banks party thereto | 8-K | 001-39729 | 10.1 | 2023-06-22 |
| 10.47‡ | Willowbrook Group Settlement Term Sheet | 10-K | 001-39729 | 10.46 | 2023-02-28 |
| 10.48‡ | Willowbrook Trial Plaintiffs Settlement Term Sheet | 10-K | 001-39729 | 10.47 | 2023-02-28 |
| 10.49‡ | Settlement Agreement dated as of March 28, 2023 by and among Sotera Health LLC, Sterigenics U.S., LLC and Plaintiffs’ Counsel (Illinois Ethylene Oxide Tort Litigation) | 10-Q | 001-39729 | 10.2 | 2023-05-08 |
| 10.50‡ | Willowbrook Group Settlement Agreement dated as of March 28, 2023 by and among Sotera Health LLC, Sterigenics U.S., LLC and Plaintiff's Executive Committee (Illinois Ethylene Oxide Tort Litigation) | 10-Q | 001-39729 | 10.3 | 2023-05-08 |
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit No | Description of Exhibits | Filed/Furnished Herewith | Form | File No. | Exhibit | Filing Date |
| 10.51+ | Form of Sotera Health Company 2020 Omnibus Incentive Plan Restricted Stock Unit Grant Notice (As Amended) and Agreement | 10-K | 001-39729 | 10.48 | 2023-02-28 | |
| 10.52+ | Form of Sotera Health Company 2020 Omnibus Incentive Plan Stock Option Grant Notice (As Amended) and Agreement | 10-K | 001-39729 | 10.49 | 2023-02-28 | |
| 21.1 | List of Subsidiaries | * | ||||
| 23.1 | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm | * | ||||
| 31.1 | Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | * | ||||
| 31.2 | Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | * | ||||
| 32.1 | Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | ||||
| 97.1 | Sotera Health Company Policy for the Recovery of Erroneously Awarded Compensation | * | ||||
| 101.INS | Inline XBRL Instance Document - The XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | * | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||
| 101.LAB | Inline XBRL Taxonomy Label Linkbase Document | * | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * | ||||
- Filed Herewith
** Furnished Herewith
- Denotes management contract or compensatory plan or arrangement.
† Certain confidential portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material, and (ii) would likely cause us competitive harm if publicly disclosed. We agree to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission on its request.
‡ Certain confidential portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material, and (ii) the type of information that the registrant treats as private and confidential. We agree to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission on its request.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.